The role of SLC26A4 sequence alterations in determining PS and EVA was firmly established by several studies, either focusing on hearing impairment [17,18], alteration of the vestibular aqueduct [19], suppression of thyroid function [20] or combinations of these clinical manifestations [21]. The gene discussed is SLC26A4; the disease is hearing loss disorder.